High‐risk human papillomavirus correlates with recurrence after laser ablation for treatment of patients with cervical intraepithelial neoplasia 3: A long‐term follow‐up retrospective study. Issue 2 (11th October 2013)

• Record Type: Journal Article
• Authors: Inaba, Kanako; Nagasaka, Kazunori; Kawana, Kei; Arimoto, Takahide; Matsumoto, Yoko; Tsuruga, Tetsushi; Mori‐Uchino, Mayuyo; Miura, Shiho; Sone, Kenbun; Oda, Katsutoshi; Nakagawa, Shunsuke; Yano, Tetsu; Kozuma, Shiro; Fujii, Tomoyuki
• Is Part Of: Journal of obstetrics and gynaecology research. Volume 40:Issue 2(2014:Feb.)
• Page Start: 554
• Page End: 560
• Publication Date: 2013-10-11
• Subjects: Gynecology -- Periodicals; Obstetrics -- Periodicals; 618.1005
• DOI: 10.1111/jog.12196
• Languages: English
• ISSNs: 1341-8076

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <sec id="jog12196-sec-0001" sec-type="section"> <title>Aim</title> <p>The purpose of our study was to evaluate the efficacy of laser ablation as a conservative treatment for cervical intraepithelial neoplasia 3 (CIN3) and assess whether the human papillomavirus (HPV) test is useful to predict recurrence after treatment.</p> </sec> <sec id="jog12196-sec-0002" sec-type="section"> <title>Materials and Methods</title> <p>A total of 134 patients who received laser ablation for treatment of CIN3 were enrolled in this study. During the follow‐up period, patients were followed with cytological and colposcopic evaluations. Recurrence of CIN3 was regarded as the primary end‐point. HPV genotype was tested before and after treatment. Post‐treatment cumulative recurrence rates were estimated and comparisons by both patient age and HPV genotype were performed.</p> </sec> <sec id="jog12196-sec-0003" sec-type="section"> <title>Results</title> <p>Overall cumulative recurrence rate of CIN3 in the first year after treatment was 22.6% for all patients. No significant correlation was shown between patient age and recurrence. Patients infected by specific genotypes (16, 18, 31, 33, 52, and 58) frequently failed to clear the infection after treatment. The 1‐year recurrence‐free survival in those positive after treatment for eight high‐risk genotypes (16, 18, 31, 33, 35, 45, 52, and 58) was significantly lower (66.7%), compared to that in those positive for other high‐risk types (78.6%). The recurrence‐free survival of those who remained HPV‐positive after treatment was significantly lower than those who turned negative.</p> </sec> <sec id="jog12196-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Laser ablation should be performed prudently with appropriate patient counseling about recurrence rate. Considering its minimal invasiveness, laser ablation is effective, especially for young patients who are negative for eight high‐risk genotypes. With regard to HPV testing, although genotyping has significant value for predicting recurrence, screening for all genotypes warrants further evaluation.</p> </sec> </abstract>